CAMBRIDGE CANCER GENOMICS

Cambridge Cancer Genomics (CCG) is a Y Combinator backed healthtech startup building tools to enable oncologists to make the best therapeutic decisions for their patients... At CCG, we believe that increasing amounts of clinical and genomic data have the potential to enable oncologists to make smarter decisions about which drug to use in which circumstance. To power our analytics, we carry out research at the cutting edge of machine learning and cancer genomics... CCG builds precision oncology solutions for all patients. Our technology can detect relapse earlier than standard of care, predict response to therapy more accurately reduce ineffective treatment regimens.

Also known as: CCG

Primary location: Cambridge United Kingdom